SAB Biotherapeutics, Inc. (SABSW) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $172.81M | +291.0% |
| 2024 | $44.20M | -47.3% |
| 2023 | $83.94M | +64.9% |
| 2022 | $50.90M | -37.3% |
| 2021 | $81.14M | +43.5% |
| 2020 | $56.54M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $172.81M | +291.0% |
| 2024 | $44.20M | -47.3% |
| 2023 | $83.94M | +64.9% |
| 2022 | $50.90M | -37.3% |
| 2021 | $81.14M | +43.5% |
| 2020 | $56.54M | — |